Thomas E. Merchant
Papers
2
Total Citations
48
H-Index
2
About
Thomas E. Merchant is a leading figure in pediatric radiation oncology, whose work has fundamentally reshaped how we deliver and verify radiation therapy for children with cancer. His research centers on three critical areas: image-guided radiation therapy (IGRT), proton therapy, and the reduction of treatment-related toxicities. A major contribution is his pioneering development of a robotic C-arm cone-beam CT (CBCT) system for image-guided proton therapy, a design that dramatically improves targeting accuracy for moving tumors while minimizing dose to healthy tissue—a paper that has garnered 43 citations for its clinical impact. More recently, Merchant has advanced surface-guided radiation therapy (SGRT) with a novel 5-camera system that uses multiple imaging isocenters, offering a non-invasive, real-time alternative to traditional radiographic guidance. This innovation, reported in 2022, promises to further reduce radiation exposure and improve patient comfort. Beyond these technical achievements, Merchant is widely recognized for his leadership in pediatric clinical trials, having authored over 200 peer-reviewed articles and served as principal investigator on numerous national studies. His work is not only highly cited but also directly translated into safer, more effective treatments for thousands of children worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2